Novo Nordisk Share Holder Equity 1988-2025 | NVO
Novo Nordisk share holder equity from 1988 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
- Novo Nordisk share holder equity for the quarter ending September 30, 2025 was $26.606B, a 49.77% increase year-over-year.
- Novo Nordisk share holder equity for 2024 was $20.805B, a 34.47% increase from 2023.
- Novo Nordisk share holder equity for 2023 was $15.473B, a 30.88% increase from 2022.
- Novo Nordisk share holder equity for 2022 was $11.822B, a 5.03% increase from 2021.
| Novo Nordisk Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024 | $20,805 |
| 2023 | $15,473 |
| 2022 | $11,822 |
| 2021 | $11,256 |
| 2020 | $9,701 |
| 2019 | $8,633 |
| 2018 | $7,926 |
| 2017 | $7,567 |
| 2016 | $6,727 |
| 2015 | $6,989 |
| 2014 | $7,184 |
| 2013 | $7,582 |
| 2012 | $7,021 |
| 2011 | $6,999 |
| 2010 | $6,591 |
| 2009 | $6,693 |
| 2008 | $-89 |
| 2007 | $5,921 |
| 2006 | $5,060 |
| 2005 | $4,615 |
| 2004 | $4,426 |
| 2003 | $3,844 |
| 2002 | $3,222 |
| 2001 | $2,392 |
| 2000 | $1,971 |
| 1999 | $2,049 |
| 1998 | $26,958 |
| 1997 | $2,729 |
| 1996 | $2,751 |
| 1995 | $2,602 |
| 1994 | |
